Related Experiment Videos
Transcription elongation and human disease
1Howard Hughes Medical Institute, Oklahoma Medical Research Foundation, Oklahoma City 73104, USA.
Annual Review of Biochemistry
|June 29, 2000
Summary
Researchers are exploring novel elongation factors like P-TEFb, ELL, CSB, and elongin, which regulate RNA polymerase II. These factors are crucial for mRNA synthesis and have links to various human diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Eukaryotic mRNA synthesis involves RNA polymerase II and stages like preinitiation, initiation, elongation, and termination.
- Research has historically focused on transcription initiation factors (TFIIB-H).
- Recent studies highlight the importance of the elongation stage.
Purpose of the Study:
- To review current understanding of elongation factors.
- To discuss their mechanisms of action.
- To explore their roles in human diseases.
Main Methods:
- Biochemical studies of eukaryotic mRNA synthesis.
- In vitro analysis of protein functions.
- Review of existing literature on elongation factors and associated diseases.
Main Results:
- Identified candidate general elongation factors: P-TEFb, ELL, CSB, and elongin.
- These factors expedite RNA polymerase II elongation by suppressing pausing and arrest.
- These factors are implicated in diverse diseases including HIV-1, leukemia, Cockayne syndrome, and von Hippel-Lindau disease.
Conclusions:
- Elongation factors play critical roles in mRNA synthesis.
- Dysregulation of these factors is linked to various human pathologies.
- Further research into these factors may reveal new therapeutic targets.